Congratulations to the 2025 cohort companies! After a competitive selection process with a 4% acceptance rate, 65 companies were chosen to participate in MTI’s flagship four-month Accelerator program. These medical device, diagnostic, and digital health companies will access the seasoned expertise of strategics, manufacturers, healthcare providers, investors, and other industry stakeholders, along with unparalleled visibility. Cohort companies will compete for over $800K in non-dilutive funding throughout the 2025 program.